JP6399920B2 - 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤 - Google Patents

体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤 Download PDF

Info

Publication number
JP6399920B2
JP6399920B2 JP2014257747A JP2014257747A JP6399920B2 JP 6399920 B2 JP6399920 B2 JP 6399920B2 JP 2014257747 A JP2014257747 A JP 2014257747A JP 2014257747 A JP2014257747 A JP 2014257747A JP 6399920 B2 JP6399920 B2 JP 6399920B2
Authority
JP
Japan
Prior art keywords
component
fucoxanthin
lactoferrin
composition
fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014257747A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016117676A5 (enExample
JP2016117676A (ja
Inventor
森下　聡
聡 森下
佳菜恵 中村
佳菜恵 中村
大原　勝義
勝義 大原
桂子 生駒
桂子 生駒
知二 小野
知二 小野
健 上北
健 上北
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Kaneka Corp
Original Assignee
Lion Corp
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp, Kaneka Corp filed Critical Lion Corp
Priority to JP2014257747A priority Critical patent/JP6399920B2/ja
Priority to PCT/JP2015/085450 priority patent/WO2016098874A1/ja
Priority to CN201580069149.8A priority patent/CN107106633A/zh
Priority to TW104142587A priority patent/TWI691334B/zh
Priority to KR1020177015167A priority patent/KR20170095843A/ko
Publication of JP2016117676A publication Critical patent/JP2016117676A/ja
Publication of JP2016117676A5 publication Critical patent/JP2016117676A5/ja
Application granted granted Critical
Publication of JP6399920B2 publication Critical patent/JP6399920B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2014257747A 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤 Active JP6399920B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2014257747A JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤
PCT/JP2015/085450 WO2016098874A1 (ja) 2014-12-19 2015-12-18 内服用組成物
CN201580069149.8A CN107106633A (zh) 2014-12-19 2015-12-18 内服用组合物
TW104142587A TWI691334B (zh) 2014-12-19 2015-12-18 內服用組成物、製劑、與用途
KR1020177015167A KR20170095843A (ko) 2014-12-19 2015-12-18 내복용 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014257747A JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤

Publications (3)

Publication Number Publication Date
JP2016117676A JP2016117676A (ja) 2016-06-30
JP2016117676A5 JP2016117676A5 (enExample) 2017-08-17
JP6399920B2 true JP6399920B2 (ja) 2018-10-03

Family

ID=56126754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014257747A Active JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤

Country Status (5)

Country Link
JP (1) JP6399920B2 (enExample)
KR (1) KR20170095843A (enExample)
CN (1) CN107106633A (enExample)
TW (1) TWI691334B (enExample)
WO (1) WO2016098874A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006083102A (ja) * 2004-09-16 2006-03-30 Four Leaf Japan:Kk 抗酸化組成物およびこれを含む製品
CA2609454A1 (en) * 2005-05-24 2006-11-30 National University Corporation Hokkaido University Agent having antiobesity activity and method of inhibiting obesity
JP5158307B2 (ja) * 2006-09-15 2013-03-06 ライオン株式会社 脂肪減少促進剤及び代謝異常症候群改善薬
CN101721403A (zh) * 2008-10-16 2010-06-09 北京绿色金可生物技术股份有限公司 岩藻黄素在减肥方面的应用
JP2011001333A (ja) * 2009-06-22 2011-01-06 Lion Corp アシル−ＣｏＡ合成阻害剤
KR101719436B1 (ko) * 2011-01-21 2017-03-23 라이온 가부시키가이샤 지방 분해 촉진 조성물
JP2013060402A (ja) * 2011-09-14 2013-04-04 Furabamin:Kk フコキサンチンおよびフコイダン含有組成物
WO2014028585A1 (en) * 2012-08-14 2014-02-20 The Texas A&M University System Compositions for targeted anti-aging therapy
CN103012327B (zh) * 2012-12-21 2015-05-13 国家海洋局第三海洋研究所 岩藻黄质的制备方法
JP6208604B2 (ja) * 2014-03-14 2017-10-04 ライオン株式会社 体脂肪低減剤

Also Published As

Publication number Publication date
CN107106633A (zh) 2017-08-29
KR20170095843A (ko) 2017-08-23
WO2016098874A1 (ja) 2016-06-23
TWI691334B (zh) 2020-04-21
TW201625293A (zh) 2016-07-16
JP2016117676A (ja) 2016-06-30

Similar Documents

Publication Publication Date Title
JP6016363B2 (ja) 脳神経細胞新生剤
JP2005068060A (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品の製造法
JP5189365B2 (ja) 体内脂質改善組成物
KR20080108523A (ko) 지방 축적 억제제
JP6293099B2 (ja) ジンセノサイドｆ２の肝疾患予防又は治療用途
TWI610680B (zh) 含有去鼠李糖洋丁香酚苷（Ｄｅｓ Ｒｈａｍｎｏｓｙｌ Ａｃｔｅｏｓｉｄｅ）之橄欖萃取物
JP2013071909A (ja) 脳内過酸化脂質蓄積抑制剤
EP2908828B1 (en) Galactagogue compositions based on phosphatidylserine
JP6460402B2 (ja) コレステロール排出促進用医薬組成物又は食品組成物
JP5706142B2 (ja) フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
JP5158307B2 (ja) 脂肪減少促進剤及び代謝異常症候群改善薬
JP6399920B2 (ja) 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤
JP2023054194A (ja) 防風通聖散エキス
JP5546833B2 (ja) アセトアルデヒド・エタノール低減剤
JP2014148467A (ja) 血中クレゾール低下剤
TWI442920B (zh) 香椿萃取物於減少體重或以降低體脂肪之藥物上之用途
EP4097126A1 (en) Compositions comprising pig stomach mucins and uses thereof
CN106999524A (zh) 含有人参籽油的用于预防和治疗前列腺肥大的组合物
JP2010105948A (ja) 脂肪肝抑制剤
JP2004002254A (ja) 植物抽出エキスを含有する腸溶性の脂肪吸収抑制剤およびそれを含有する食品
JP7137368B2 (ja) ナトリウム排泄促進用及び／又はナトリウム吸収抑制用組成物
JP2018008912A (ja) 臓器線維化抑制組成物
WO2022085603A1 (ja) 筋量増加、筋力増加、筋量減少抑制又は筋力低下抑制用組成物
TW202513087A (zh) 腎功能之增進或改善用組合物
JP2024051747A (ja) 炎症性腸疾患改善剤、炎症性腸疾患改善用食品添加剤、炎症性腸疾患改善用飲食品、炎症性腸疾患改善用製剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170704

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180425

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180814

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180904

R150 Certificate of patent or registration of utility model

Ref document number: 6399920

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250